2017 American Transplant Congress
Conversion from Twice Daily to Once Daily Tacrolimus Improves Adherence in Kidney Transplant Recipients.
INTRODUCITON AND OBJECTIVE: Kidney transplant longevity is largely related to immunosuppressive efficacy, which is highly dependent on patient adherence. Drug dosing frequency is one way…2017 American Transplant Congress
The Associations Between Immunosuppression Use, Loss of Medicare and Kidney Allograft Outcomes.
Medicare coverage for kidney transplant recipients aged <65 years in the US ends 3 years posttransplant, but a significant proportion of recipients remain on Medicare…2017 American Transplant Congress
Clinical Outcomes of Simplified Once-Daily Immunosuppressive Regimen for Stable Kidney Recipients.
Aims. Many immunosuppressive drugs are prescribed as twice-daily dosing. Simplified once-daily dosing of the entire drug regimen can improve treatment satisfaction for patients. We examined…2017 American Transplant Congress
Practice Patterns in the Treatment and Monitoring of Acute Cell-Mediated Kidney Graft Rejection in Canada.
Aim: to gather clinicians' views and practice patterns on the diagnosis, treatment and monitoring of acute T-cell mediated rejection (TCMR) in Canada.Methods: As part of…2017 American Transplant Congress
Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.
The risk of mortality and graft loss is higher in kidney transplant recipients with reduced estimated glomerular filtration rate (eGFR) and heavier albuminuria. It is…2017 American Transplant Congress
Primary Hyperoxaluria Type-1 in Chinese Population: A Case Series and Review of Literature.
Background: Primary hyperoxaluria type 1 (PH1) is rare but devastating autosomal recessive inherited disease and cause to graft failure after kidney transplant (KT). We report…2017 American Transplant Congress
Intraoperative Fluid Management During Pediatric Kidney Transplantation with Less Than 15kg Body Weight Using Transesophageal Echocardiaography as Hemodynamic Parameter.
Introduction: To avoid low output syndrome (LOS) and delayed graft function (DGF), precise intraoperative hemodynamic monitoring are mandatory for small pediatric recipients with adults' donor…2017 American Transplant Congress
Does Simultaneous Liver Kidney Transplant in Patients with MELD ≥35 on Renal Replacement Therapy at the Time of Transplant Improve Outcome?
Transplant Hepatology, Univ. of Tennessee, Memphis, TN
Background: A significant proportion of patients with MELD ≥35 have renal failure requiring renal replacement therapy (RRT) at the time of transplant, and receive either…2017 American Transplant Congress
Prospective DSA Monitoring and Significance of De Novo DSA in Adult Liver Transplantation.
Background: Post transplant course of circulating de novo donor specific antibodies (DSA) remains unknown after liver transplantation (LT).Methods: In a prospective study, sera from 92…2017 American Transplant Congress
Steroid-Free Immunosuppression After Liver Transplant for Autoimmune Disease Does Not Result in Increased Disease Recurrence.
Immunosuppression regimens in patients with end stage liver disease (ESLD) from autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) typically include…
American Transplant Congress abstracts